AMERIPRISE FINANCIAL INC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2021$44,785,000
-13.4%
2,391,003
-3.6%
0.01%
-12.5%
Q2 2021$51,734,000
-26.0%
2,481,228
+0.3%
0.02%
-30.4%
Q1 2021$69,944,000
+102.5%
2,474,145
+133.9%
0.02%
+91.7%
Q4 2020$34,544,000
+2834.9%
1,057,665
+1472.5%
0.01%
Q3 2018$1,177,000
+142.7%
67,260
+152.5%
0.00%
Q2 2018$485,00026,6400.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$34,650,0005.10%
COMMODORE CAPITAL LP 999,433$18,719,0004.94%
Affinity Asset Advisors, LLC 530,000$9,927,0002.51%
EcoR1 Capital, LLC 3,724,437$69,759,0002.43%
Ghost Tree Capital, LLC 425,000$7,960,0002.33%
Asymmetry Capital Management, L.P. 194,309$3,639,0002.19%
ACUTA CAPITAL PARTNERS, LLC 291,884$5,467,0001.93%
Sio Capital Management, LLC 228,318$4,276,0001.36%
SPHERA FUNDS MANAGEMENT LTD. 788,735$14,773,0001.24%
BVF INC/IL 1,635,112$30,626,0001.20%
View complete list of KURA ONCOLOGY INC shareholders